<--- Back to Details
First PageDocument Content
Tendai / Pure Land Buddhism / Genshin / Nichiren / Shinran / Nondualism / Eisai / Buddhism / Buddhism in Japan / Religion
Date: 2010-05-05 14:09:26
Tendai
Pure Land Buddhism
Genshin
Nichiren
Shinran
Nondualism
Eisai
Buddhism
Buddhism in Japan
Religion

Add to Reading List

Source URL: www.princeton.edu

Download Document from Source Website

File Size: 294,30 KB

Share Document on Facebook

Similar Documents

Application of Natural Resources to Drug Discovery in Eisai Research and Development of Eribulin mesylate Katsuya Tagami, Eisai Co., Ltd. Eribuin mesylate is a first-in class, non-taxane microtubule dynamics inhibitor th

Application of Natural Resources to Drug Discovery in Eisai Research and Development of Eribulin mesylate Katsuya Tagami, Eisai Co., Ltd. Eribuin mesylate is a first-in class, non-taxane microtubule dynamics inhibitor th

DocID: 1uZFZ - View Document

To Whom It May Concern, October 13, 2017 Taisho Pharmaceutical Co., Ltd. Eisai Co., Ltd. Toyama Chemical Co., Ltd.

To Whom It May Concern, October 13, 2017 Taisho Pharmaceutical Co., Ltd. Eisai Co., Ltd. Toyama Chemical Co., Ltd.

DocID: 1ugwQ - View Document

11. Major R&D Pipeline In-House R&D Pipeline List Additional Indication, etc.**  Product Name / Development Code

11. Major R&D Pipeline In-House R&D Pipeline List Additional Indication, etc.** Product Name / Development Code

DocID: 1sXjF - View Document

ご使用に際して、 この説明書を必ずお読みください。 また、必要な時に読めるよう大切に保管してください。 メコバラミン主薬製剤 第3類医薬品

ご使用に際して、 この説明書を必ずお読みください。 また、必要な時に読めるよう大切に保管してください。 メコバラミン主薬製剤 第3類医薬品

DocID: 1sWWa - View Document

June 17, Koishikawa, Bunkyo-ku, Tokyo Eisai Co., Ltd. Director, Representative Corporate Officer and CEO Haruo Naito Dear shareholders:

June 17, Koishikawa, Bunkyo-ku, Tokyo Eisai Co., Ltd. Director, Representative Corporate Officer and CEO Haruo Naito Dear shareholders:

DocID: 1siNy - View Document